About me
Fiona Mack is currently Vice President, Head of Bayer Co.Lab Cambridge, US, which is a part of the Business Development & Licensing function. In this role, she is building a life science incubator to accelerate innovations within the
fields of cell and gene therapy, oncology, immunology, cardiovascular medicine and digital health.
Prior to joining Bayer, as Head of JLABS@ TMC, Fiona was responsible for external engagement, innovation sourcing, company onboarding, portfolio management, operational excellence, educational programming and P&L. She catalyzed and supported the translation of science and technology into valuable solutions for patients and consumers across the pharmaceutical, medical device, consumer and healthtech sectors.
Fiona has held senior leadership positions at Ipsen, Roche and Pfizer supporting external innovation efforts to expand Rare Disease, Neuroscience and Oncology portfolios.
Fiona earned her Ph.D. in Cell and Molecular Biology from the University of Pennsylvania and her undergraduate degree in Biology from Cornell University. Her innovative work has been published in high impact journals and she also has several granted patents.
